CJC1295 (No DAC) + Ipamorelin
CJC-1295 No DAC + Ipamorelin – Research Peptide Blend (10mg Vial)
CJC-1295 No DAC + Ipamorelin is a high-purity research-grade peptide blend supplied by Peptide Fusion Au exclusively for laboratory and educational research purposes.
This 10mg vial contains 5mg CJC-1295 No DAC (a modified growth hormone-releasing hormone analogue) and 5mg Ipamorelin (a selective ghrelin receptor agonist). In laboratory and preclinical studies, this combination has been investigated for its synergistic effects on stimulating pulsatile growth hormone (GH) release from the pituitary gland. CJC-1295 No DAC acts on GHRH receptors while Ipamorelin acts on ghrelin receptors, allowing researchers to study complementary secretagogue pathways with reduced impact on cortisol and prolactin levels compared to some other GH-releasing compounds.
Key Specifications
• Research Use Only (RUO)
• 10mg total per vial (5mg CJC-1295 No DAC + 5mg Ipamorelin)
• High purity (typically ≥98% by HPLC – Certificate of Analysis available upon request)
• Supplied as a lyophilized powder for laboratory reconstitution
Intended Use
CJC-1295 No DAC + Ipamorelin is sold solely for use in controlled scientific research and laboratory experimentation by qualified professionals. It is commonly studied in in vitro and preclinical models to explore growth hormone regulation, pituitary signaling, synergistic secretagogue mechanisms, and related endocrine and metabolic pathways.
All customers are responsible for ensuring that their intended use complies with all applicable Australian federal, state, and territory laws and regulations, including any requirements set by the Therapeutic Goods Administration (TGA) or other relevant authorities.
Important Notice
Peptide Fusion Au products, including CJC-1295 No DAC + Ipamorelin, are not approved for human or veterinary use. They are not medicines, supplements, cosmetics, or therapeutic agents of any kind.
This product is not for human or animal consumption, and it is not intended for diagnostic, therapeutic, prophylactic, or any other medical or personal use. No dosing instructions, administration guidance, or claims regarding physiological effects in humans are provided or implied.
Any references to mechanisms or effects are derived from published scientific literature on laboratory or preclinical research models and do not constitute recommendations for use outside of controlled research settings.
By purchasing CJC-1295 No DAC + Ipamorelin from Peptide Fusion Au, you confirm that you are acquiring it strictly for legitimate laboratory research purposes only and that you have read and agree to the terms outlined in our Legal, Shipping & Refund Policy.